Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Anna Protopapas > Profile

Anna Protopapas

Affiliations

  • at Nuvalent Inc. (NUVL), 2025-06-20
  • Director at Mersana Therapeutics Inc. (MRSN), 2025-06-13
  • Director at Dicerna Pharmaceuticals Inc (DRNA), 2021-06-08
  • Director at Bioverativ Inc. (BIVV), 2018-03-08
  • Director at Ariad Pharmaceuticals Inc (ARIA), 2017-02-16
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
MRSN $0.58 8,637 $5,009.46 168,041 2025-01-16 Filing
MRSN $0.63 6,191 $3,900.33 155,428 2025-01-15 Filing
MRSN $0.66 11,534 $7,612.44 144,869 2025-01-14 Filing
MRSN $2.71 29,399 $79,671.29 125,153 2024-01-16 Filing
NUVL $75.67 5,000 $378,350.00 0 2023-12-18 Filing